Search

everythinglearnresearchcommunity

for

Search:↓

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

A patient with a skin condition had unusual scarring hair loss but improved with treatment.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

Increased sunscreen use may be linked to frontal fibrosing alopecia in Hispanic females.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

FFA patients have fewer melanocytes and thinner skin compared to others.

Red dots on the upper chest may be an early sign of certain types of hair loss.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

Women with Frontal Fibrosing Alopecia have more wrinkles near their ears than similar aged women without the condition.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.